Inve India ▾
ININDGN

Indegene Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 31 Jul 2026

Indegene reported strong Q1 FY27 results with revenues reaching INR 10,631 million, marking a 39.7% YoY and 6% QoQ growth, the strongest first-quarter sequential growth in four years. The company expanded its active client base to 105 and increased its $10-$25 million client cohort to 9. While EBITDA margins saw a sequential decline due to one-time workforce transformation costs and slow revenue recognition from new Gen AI engagements, management expects a recovery to historical levels by Q4 FY27.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q1 FY27: revenue up 33.2%, net profit up 33.3% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue282 287 267 256 307 +9%290 +1%368 +38%341 +33%
EBITDA46 52 40 37 71 +54%38 −27%103 +158%60 +62%
Net profit45 50 54 45 60 +33%35 −30%72 +33%60 +33%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.